SE442864B - 1,4-dihydropyridinforeningar - Google Patents

1,4-dihydropyridinforeningar

Info

Publication number
SE442864B
SE442864B SE8205905A SE8205905A SE442864B SE 442864 B SE442864 B SE 442864B SE 8205905 A SE8205905 A SE 8205905A SE 8205905 A SE8205905 A SE 8205905A SE 442864 B SE442864 B SE 442864B
Authority
SE
Sweden
Prior art keywords
group
nitrophenyl
dihydropyridine
compound
dimethyl
Prior art date
Application number
SE8205905A
Other languages
English (en)
Swedish (sv)
Other versions
SE8205905D0 (sv
SE8205905L (sv
Inventor
S Ohno
K Mizukoshi
O Komatsu
K Ichihara
T Morishima
Original Assignee
Maruko Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16696381A external-priority patent/JPS5867668A/ja
Priority claimed from JP259782A external-priority patent/JPS58121288A/ja
Priority claimed from JP2839182A external-priority patent/JPS58146565A/ja
Application filed by Maruko Pharmaceutical Co filed Critical Maruko Pharmaceutical Co
Publication of SE8205905D0 publication Critical patent/SE8205905D0/xx
Publication of SE8205905L publication Critical patent/SE8205905L/xx
Publication of SE442864B publication Critical patent/SE442864B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8205905A 1981-10-19 1982-10-18 1,4-dihydropyridinforeningar SE442864B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16696381A JPS5867668A (ja) 1981-10-19 1981-10-19 1,4−ジヒドロピリジン誘導体
JP259782A JPS58121288A (ja) 1982-01-11 1982-01-11 1,4−ジヒドロピリジン誘導体
JP2839182A JPS58146565A (ja) 1982-02-24 1982-02-24 1,4−ジヒドロピリジン誘導体

Publications (3)

Publication Number Publication Date
SE8205905D0 SE8205905D0 (sv) 1982-10-18
SE8205905L SE8205905L (sv) 1983-04-20
SE442864B true SE442864B (sv) 1986-02-03

Family

ID=27275435

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8205905A SE442864B (sv) 1981-10-19 1982-10-18 1,4-dihydropyridinforeningar

Country Status (12)

Country Link
US (1) US4446325A (de)
KR (1) KR880002704B1 (de)
AU (1) AU555036B2 (de)
CA (1) CA1177079A (de)
CH (1) CH650498A5 (de)
DE (1) DE3238705A1 (de)
ES (2) ES517022A0 (de)
FR (1) FR2514761B1 (de)
GB (1) GB2111978B (de)
IT (1) IT1189393B (de)
NL (1) NL194203C (de)
SE (1) SE442864B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
DE3514865A1 (de) * 1985-04-25 1986-11-06 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
DE3682208D1 (de) * 1986-12-18 1991-11-28 Kurt Heinz Bauer Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
ES2287110T3 (es) * 2000-04-11 2007-12-16 Sankyo Company, Limited Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina.
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
RU2007106714A (ru) * 2004-07-26 2008-09-10 Байер Шеринг Фарма Аг (De) Лечение легочной гипертензии путем ингаляции илопростата с препаратом микрочастиц
EP2351569B1 (de) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Kombinationstherapie mit Fasudil zur Behandlung von pulmonaler Hypertonie
EP2111863B1 (de) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in Kombination mit Bosentan zur Behandlung von pulmonaler arterieller Hypertonie
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
EP2747757A1 (de) 2011-08-26 2014-07-02 Wockhardt Limited Verfahren zur behandlung kardiovaskulärer erkrankungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines

Also Published As

Publication number Publication date
GB2111978B (en) 1985-05-01
ES8504127A1 (es) 1985-04-16
IT8249295A0 (it) 1982-10-18
CA1177079A (en) 1984-10-30
US4446325A (en) 1984-05-01
KR840001954A (ko) 1984-06-07
NL194203C (nl) 2001-09-04
ES8406439A1 (es) 1984-08-16
IT1189393B (it) 1988-02-04
AU555036B2 (en) 1986-09-11
KR880002704B1 (ko) 1988-12-26
NL8204014A (nl) 1983-05-16
ES527980A0 (es) 1985-04-16
AU8931782A (en) 1983-04-28
DE3238705C2 (de) 1989-11-09
DE3238705A1 (de) 1983-07-14
GB2111978A (en) 1983-07-13
SE8205905D0 (sv) 1982-10-18
FR2514761A1 (fr) 1983-04-22
NL194203B (nl) 2001-05-01
CH650498A5 (de) 1985-07-31
SE8205905L (sv) 1983-04-20
ES517022A0 (es) 1984-08-16
FR2514761B1 (fr) 1985-09-06

Similar Documents

Publication Publication Date Title
SE442864B (sv) 1,4-dihydropyridinforeningar
EP0266922B1 (de) Dihydropyridin-Derivate, ihre Herstellung und ihre Verwendung
HU194171B (en) Process for preparing asymmetric diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid and pharmaceuticals comprising such compounds
CZ127396A3 (en) Short time acting dihydropyridines
CA1238048A (en) Cardiovascular active 1,4,:3,6-dianhydrohexitol esters of 1,4-dihydropyridine-3,5-dicarboxylic acids
US4472411A (en) 1,4-Dihydropyridine derivatives and use as vasodilators
EP0080220B1 (de) Dihydropyridine, Verfahren zu ihrer Herstellung, ihre Zusammensetzungen und ihre Verwendung als Arzneimittel
HU184434B (en) Process for preparing 1,4-dihydro-pyridine derivatives containing different substituents in position 2. and 6. and pharmaceutical compositions containing such compounds as active substances
OHNO et al. Synthesis of asymmetric 4-aryl-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylates with vasodilating and antihypertensive activities
US4166855A (en) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator
EP0207674B1 (de) 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
SK48094A3 (en) Condensated chinolyl-dihydropyridines, method of their production, treatments containing these matters, method of production and using of these compounds
US4874773A (en) 3-Aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, and pharmaceutical composition containing the same
US4900833A (en) Asymmetrical ester derivatives of 1,4-dihydropyridine-3,5-dicarboxylic acid
EP0093945B1 (de) 1,4-Dihydropyridin-Derivate
US4795814A (en) Process for preparing novel dihydropyridine derivatives
US4364952A (en) Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use
GB1568723A (en) Sulphur-containing amino-dihydropyridines process for their preparation and their use as medicaments
US4891373A (en) Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments
IE43984B1 (en) A 1,4-dihydropyridine-3 5-dicarboxylic acid di-ester derivative, several processes for its preparation,and its use as a coronary therapeutic agent
JPS6330304B2 (de)
FI85491B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fosfonsyraderivat.
HUT70155A (en) 1,4-dihydropyridine-3,5-dikarboxylic acid ester derivative, pharmaceutical compositions comprising them and process for producing thereof
EP0220917B1 (de) Pharmazeutische 1,4-Dihydropyridinderivate, ihre Salze und Herstellung
EP0319030A1 (de) Aminopropanol-Derivate von 1,4:3,6-dianhydro-hexitolnitraten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8205905-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8205905-6

Format of ref document f/p: F